Skip to main content
Premium Trial:

Request an Annual Quote

HTG Molecular EdgeSeq Pan B-Cell Lymphoma Panel

HTG Molecular Diagnostics has pre-launched its HTG EdgeSeq Pan B-Cell Lymphoma Panel, which the firm expects to offer as a kit or as a service for research use only use starting in July. The panel is designed to provide molecular characterization of aggressive lymphomas by allowing researchers to measure the expression of genes linked to the aggressive lymphoma transcriptome. The panel is an extension of HTG's DLBCL assay. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.